name: Decreased sensitivity of central visual field


name: Bone spicule-like pigmentation in peripheral retina


name: Diffuse pigment mottling in peripheral retina


name: Butterfly surrounded by hypopigmentation


name: Pigmentation consists of closely packed pigment granules in the retina pigment epithelium (RPE)


name: Decreased postsynaptic areas of clefts and folds seen on muscle biopsy


name: Increased number of endplate regions distributed over increased span of muscle fiber


name: Poor development of the postsynaptic membrane


name: Preserved junctional structure seen on muscle biopsy


name: Preserved nerve terminals seen on muscle biopsy


name: Increased length of endplate regions seen on muscle biopsy


name: Increased numbers of endplate regions seen on muscle biopsy


name: Decreased numbers of AChR seen on muscle biopsy


name: Decremental compound muscle action potential (CMAP) in response to repetitive nerve stimulation seen on EMG


name: Distal muscle atrophy due to peripheral neuropathy, lower limbs more affected than upper limbs


name: Distal muscle weakness due to peripheral neuropathy, lower limbs more affected than upper limbs


name: Reduced stomatin at the erythrocyte membrane


name: In vitro hyperkalemia (pseudohyperkalemia) due to rupture of erythrocyte membranes


name: Macular retinal pigment epithelium pigmentation


name: Macular retinal pigment epithelium atrophy


name: Necrosis of bone and marrow tissue on histopathology


name: Hearing loss, sensorineural (0.5 - 2.0 kHz)


name: Lower motor neuron signs in lower limbs or all limbs


name: Generalized lipodystrophy (abnormal distribution of subcutaneous fat)


name: Transient otoacoustic emission spectra absent indicating a deficiency of outer hair cell function


name: Hearing loss, sensorineural, bilateral symmetrical, progressive (severe later in life)


name: Hearing loss, progressive, mild to severe


name: Capillary malformations, commonly on face or neck, rarely on mucosa


name: Spinal disc herniation, various regions of the spine


name: Pyramidal signs secondary to spinal cord compression


name: Electron-dense aggregates of keratin filaments in basal keratinocytes


name: Prominent intercellular edema of the basal and suprabasal cell layers


name: Mild intercellular edema of the spinous cell layer


name: Electron-lucent holes in some cells of granulary layer


name: Swollen cells with loosely assembled filament bundles in the stratum lucidum


name: Disturbed lamellar lipid organization in the stratum corneum


name: Cytolysis and fragmentation of keratin filaments in corneocytes


name: Cleavage within stratum corneum and immediate subcorneal layer


name: Multiple layers of loosely packed, less densely stained, swollen cells in the stratum corneum


name: Generalized dry skin with fine scaling and sparing of face


name: Well-circumscribed peeling of the skin on the extremities and neck (easily elicited by moisture and minor trauma)


name: Hearing loss, postlingual, slowly progressive, bilateral and symmetric (moderate to severe)


name: Myxomatous degeneration of mitral valve leaflets


name: Delayed eruption of the upper median incisors


name: EMG consistent with chronic neurogenic disorder


name: Fiber-type predominance seen on muscle biopsy


name: Hearing loss, sensorineural, postlingual progressive (mainly affecting 125Hz to 2,000 Hz)


name: Multifocal yellow-white geographic, solid, choroidal lesions along the retinal vascular arcades


name: Hearing loss, sensorineural, progressive (moderate to severe)


name: Hearing loss, sensorineural (bilateral, profound, and prelingual)


name: Dark brown, hard, adherent scales on neck, elbows, and knees


name: Hearing loss, sensorineural bilateral symmetric, progressive (high frequency loss followed by middle frequency loss)


name: B-cell lymphocytosis, B-cell, polyclonal


name: Susceptibility to EBV and CMV infections


name: Poor antigen specific T-cell proliferation


name: Increased nonspecific CD8+ T-cell proliferation


name: Hearing loss, mild to profound (mainly between frequencies 0.5kHz and 4kHz)


name: Nonmedullary thyroid carcinoma (follicular)


name: Increased erythrocyte adenosine deaminase activity


name: Immobile thumbs at the interphalangeal joint


name: Small or atretic external auditory canals


name: Hearing loss, progressive (progressing from mild to severe or profound)


name: Prolonged rise and decay of miniature endplate potentials (MEPP)


name: Fibrovascular mass at junction between vascularized and nonvascularized retina Vitreous bands


name: Reduced compound muscle action potential


name: Chromosomal breakage induced by diepoxybutane (DEB), and mitomycin C


name: Increased susceptibility to solid cancers


name: Psoriasiform keratoses on knees, extensor surfaces of legs, and dorsum of feet


name: Transient pruritic vesicles on trunk, abdomen, and limbs


name: Follicular keratosis on elbows and knees


name: Striated lichenoid keratoses in major flexural folds


name: Muscle biopsy shows loss of type 2A fibers


name: Hearing loss, bilateral, moderate to profound (normal to mild at low frequencies, normal to profound in middle frequencies, and moderate to profound at high frequencies)


name: Kleeblattschaedel deformity (clover-leaf skull anomaly trilobular skull with craniosynostosis)


name: Cortical thickening at the bottom of the sulcus


name: Intranuclear granules in upper granular cells


name: Erythematous hyperkeratotic plaques on extremities


name: Ichthyosiform dermatosis, diffuse generalized


name: Hearing loss, sensorineural (moderate to profound)


name: Hearing loss, sensorineural, fluctuating (predominantly affecting high frequencies)


name: High frequency sloping audiometric profile


name: Hearing loss, severe-to-profound (70-110 dB on all frequencies, most pronounced in mid-frequencies)


name: 'Starry sky' staining of basal laminar drusen on fluorescein angiography


name: Early hyperfluorescence on fluorescein angiography


name: Geographic atrophy of retinal pigment epithelium


name: Hearing loss, sensorineural, profound (prelingual onset)


name: Inflammatory cell infiltrate in dermis and epidermis


name: Decreased compound muscle action potential amplitude


name: Loss of myelinated fibers in the anterolateral columns


name: Swelling of the proximal and distal interphalangeal joints


name: Deformities and bowing of the long bones


name: Swelling and deformity of the mandible and maxilla


name: Lack of elastic fibers in reticular dermis


name: Thin translucent skin with prominent venous patterning


name: Excessive bruising and scarring after injuries and scratching


name: Abnormal distribution of sulfur-rich proteins in the cortex and hair cuticle


name: Reduced cysteine/cystine and sulfur content


name: Recurrent infections (enteritis, otitis, and urinary infection)


name: Diffuse signal hyperintensity of white matter seen on MRI


name: Moderate to marked myocyte hypertrophy seen on biopsy


name: Decremental CMAP response to repetitive nerve stimulation seen on EMG


name: Repetitive compound muscle action potentials (CMAP) in response to single stimulus


name: Indentations of upper and lower vertebral endplates


name: Fibrofatty replacement of myocardial muscle fibers


name: Absence of insertion of keratin intermediate filaments


name: Clumping of keratin intermediate filaments


name: Widening of intercellular spaces, especially in spinous layer


name: Hyperkeratosis and fissuring around orifices


name: Low plasma levels of citrulline, ornithine, proline, and arginine


name: Fat droplets in sarcoplasm and mitochondria seen on skeletal muscle biopsy


name: Diffuse bone spicule-like pigment clumping within the neurosensory retina


name: Loss of both large and small myelinated fibers seen on sural nerve biopsy


name: Normal or mildly decreased nerve conduction velocities (NCV)


name: Deposition of complement proteins C5b-9 of the membrane attack complex on muscle fibers


name: Sarcoplasmic or subsarcolemmal vacuoles in muscle fibers seen on muscle biopsy


name: Myotonic discharges in the absence of clinical myotonia seen on EMG


name: Cyanosis due to respiratory insufficiency


name: Chorioretinal scarring in temporal periphery


name: Pigmentary abnormalities along the lines of Blaschko


name: Ankylosis of the metacarpophalangeal joint of P1


name: Gluteal crease with sacral caudal remnant


name: Increased plasma 8-dihydrocholesterol and 8(9)-cholestenol


name: Sulfur deficiency seen on amino acid analysis


name: Tiger-tail pattern seen on polarizing light microscopy


name: Partial absence of posterior portion of corpus callosum


name: High thyroid-stimulating hormone (TSH) levels


name: Linear atrophic hyperpigmented streak on left index finger


name: Atrophic hyperpigmented streaks on face and neck


name: Sparse eyelashes on the medial lower lid


name: Absent or hypoplastic external ear canals


name: Learning disability, mild (in one female)


name: Short stature (adult height <3rd centile)


name: Decreased or absent sensory nerve action potential amplitudes


name: Decreased or absent sensory nerve conduction velocities


name: Balanced reciprocal translocation, 46,XX,t(X|15)(q13.3|cen)


name: Emotionally unstable with rage-type responses


name: Thinning of choroid on ocular coherence tomography


name: Reduced cone responses on electroretinography (ERG)


name: Dark adaptation defective in both cones and rods


name: Normal spectrin membrane binding and binding sites (ankyrin)


name: Spherocytosis Red cell membranes deficient in spectrin with band 1 reduced more than band 2


name: Increased plasma and CSF 27-hydroxycholesterol


name: Delayed ossification of cranial vault in infancy


name: Poor metaphyseal flaring long tubular bones


name: Poor diaphyseal constriction long tubular bones


name: Absent phosphorylase kinase activity in myocardial tissue


name: Markedly increased glycogen in myocardium


name: Increased glycogen in muscle (but to a lesser extent than in the heart)


name: Increase in the ratio between the size of the matrix and the core of the specific granules seen on EM


name: Eosinophil nuclear hypersegmentation, hypogranulation, and negative peroxidase and phospholipid staining


name: Malignant transformation of choroid plexus papilloma


name: Intraventricular choroid plexus papilloma


name: High signal intensity of the white matter later seen on MRI


name: Hypointensity of the thalami early-on seen on MRI


name: Focal loss of cross striations seen on muscle biopsy


name: Cores of myofibrillar disruption with associated absence of mitochondria


name: Variation in fibrodiameter seen on muscle biopsy


name: Subsarcolemmal aggregates of abnormal mitochondria with concentric lamellar membranes


name: Disarray of mitochondrial cristae seen on muscle biopsy


name: Urinary excretion of cysteine and cysteamine conjugates of methacrylic acid


name: T2-weighted hyperintensities in the basal ganglia consistent with Leigh syndrome


name: Small cardiomyocytes with little cytoplasm


name: Chromosome inversion - inv2(p12q14) in 2 patients


name: Inflammatory infiltrate in lamina propria


name: Decreased expression of neonatal Fc receptor


name: Decreased cell surface expression of MHC-I


name: Decreased or absent beta-2-microglobulin


name: Inappropriately normal inhibin-B (INHBB) levels


name: Normal to high follicle-stimulating hormone (FSH) levels


name: Low to undetectable luteinizing hormone levels


name: Straight retinal vessels arising from peripheral optic disc


name: Severely reduced to nonrecordable electroretinograms


name: Complex lipid inclusions in corneal and conjunctival fibroblasts


name: Numerous small, round, keratin-containing cysts


name: Small, pit-like, atrophic areas (0.25-2.0mm) predominantly on cheeks


name: Pit-like depressions on the skin of cheeks and preauricular areas


name: Elevated ACTH-stimulated 17-hydroxypregnenolone to cortisol ratios


name: Elevated ACTH-stimulated 17-hydroxypregnenolone levels


name: Elevated baseline 17-hydroxypregnenolone levels


name: Nonmedullary thyroid carcinoma (papillary and follicular)


name: Increased autohemolysis and increased osmotic fragility at 5 degrees compared to 37 degrees C


name: High sodium/low potassium red blood cells


name: Loss of permanent teeth due to short roots


name: Bimodal erythrocyte volume distribution curve


name: Dimorphic appearance of red cells on smear


name: Red blood cells may be microcytic or macrocytic


name: Autosomal dominant (another allele in trans may be required)


name: Pleomorphic benign salivary gland adenoma (PSA)


name: Reduced FEV1/inspiratory vital capacity (IVC) ratio


name: Reduced forced expiratory volume in 1 second (FEV1)


name: Nonspecific perivascular infiltrate of chronic inflammatory cells


name: Giant plaque of porokeratosis ptychotropica


name: Non-actinic disseminated superficial porokeratosis


name: Central atrophic area with peripheral keratotic ridge


name: Vertical columns of parakeratosis (cornoid lamella) overlying area of hypogranulosis with dyskeratotic cells


name: Osteolytic lesions mainly affecting the appendicular skeleton


name: Preaxial polydactyly (bilateral or unilateral)


name: Postaxial polydactyly (bilateral, sometimes extra digits are well formed and articulated)


name: Increased and disorganized bone remodeling


name: Patches of tightly curled scalp hair adjacent to straight hair


name: Raised, scaly, and/or hyperkeratotic areas of skin


name: Increased internal nuclei seen on muscle biopsy


name: Muscle, weakness, distal, hands and fingers


name: Circumferential skin creases on extremities


name: Accumulation of basement membrane-like extracellular matrix


name: Thickened juxtacanalicular connective tissue


name: Lack of ossification in the superior portion of the frontal, parietal, and occipital bones


name: Anterior hyperreflective anomalies at the Bowman layer level


name: Broadening of the femoral neck (mid-childhood)


name: Irregular proximal epiphyseal line of the femur (early childhood)


name: Delayed appearance the secondary ossification center of the femoral head (early childhood)


name: Freckling in a butterfly pattern on the face


name: Giant pigmented hairy nevus, often in lumbosacral distribution


name: Abnormal electroretinogram (ERG) once overt maculopathy develops


name: Pigment dispersion with ocular hypertension or glaucoma


name: Recurrent choroidal and subretinal neovascular membrane formation with subsequent hemorrhage


name: Atrophy of the choriocapillaris and retinal pigment epithelium


name: Yellow deposits on Bruch membrane, beginning in the temporal macula


name: Severe visual loss (to 20/200 or worse--legal blindness), in the 4th to 6th decade


name: Incomplete symptom resolution after endothelial keratoplasty


name: Anterior and posterior corneal backscatter


name: Anterior and posterior wavefront higher-order aberrations


name: Severely abnormal electroretinogram, with rod and cone function similarly affected


name: Loss of the macular choriocapillaris on fluorescein angiography


name: Macular retinal pigment epithelium window defects on fluorescein angiography


name: Drusen-like deposits in central macular region


name: Increased interocular distance (not ocular hypertelorism)


name: Compact orthohyperkeratosis with retained nuclei


name: Erythematous indurated plaques on the shins


name: Dystrophic epidermolysis bullosa (predominantly but not restricted to the pretibial area)


name: Erosions, congenital, on dorsal and/or plantar surface of hands and feet


name: Localized hives with erythema, edema, and pruritus after repetitive vibratory or stretching stimulation


name: Increased serum histamine level during urticarial episodes


name: Late recurrence after phototherapeutic keratectomy


name: Diffuse subepithelial opacities in paracentral cornea


name: Absence of hexagonal endothelial cell pattern in zone of specular reflection


name: Abnormal morphology of endothelial cells of posterior cornea


name: Reduced number of endothelial cells of posterior cornea


name: Beaten copper appearance on retroillumination


name: Accumulation of material posterior to Descemet membrane


name: Irregular white areas on posterior surface of Descemet membrane


name: Thickening of non-banded zone of Descemet membrane


name: Geographic lesions on posterior corneal surface


name: Focal opacities on posterior corneal surface


name: Absent ossification of proximal tibial, and distal femoral epiphyses


name: Sex reversal in some karyotypic males (ovarian, mullerian duct, and vaginal development in XY individuals)


name: Altered baroreflex blood pressure regulation


name: Neurovascular contact at the rostral-ventrolateral medulla


name: Sclerae blue at birth but normal by 1 year of age


name: 'Popcorn epiphyses' in the distal femora and proximal tibiae


name: Marked deformity of upper and lower extremities


name: Recurrent diaphyseal fractures of weight-bearing bones


name: Metaphyseal and compression fractures of long bones in infancy


name: Decreased bone formation on transiliac biopsy


name: Decreased trabecular volume on transiliac biopsy


name: Widening of coronal, sagittal, and lambdoid sutures


name: Cuticular weathering on electron microscopy


name: Perivascular lymphocytic infiltration in papillary dermis


name: Keratosis pilaris of trunk and extremities


name: Hyperkeratosis of perianal areas, auricles, knuckles, knees, and ankles


name: Transgradient palmoplantar keratoderma on dorsal hands and feet


name: Focal palmoplantar keratoderma on weight-bearing areas


name: Reduced or absent acrosin in the acrosome


name: activation of maternal process involved in parturition


name: inhibition of maternal process involved in parturition


name: regulation of antigen processing, endogenous antigen via MHC class I


name: activation of transformation of host cell by virus


name: inhibition of transformation of host cell by virus


name: response to the introduction of novel objects


name: stress-activated AMP-activated protein kinase signaling cascade


name: ligand-gated ion channel signaling pathway


name: regulation of vascular associated smooth muscle cell membrane depolarization


name: positive regulation of maternal process involved in parturition


name: negative regulation of maternal process involved in parturition


name: positive regulation of wax biosynthetic process


name: regulation of basement membrane assembly involved in embryonic body morphogenesis


name: positive regulation of transformation of host cell by virus


name: negative regulation of transformation of host cell by virus


name: regulation of adipose tissue development


name: positive regulation of convergent extension involved in somitogenesis


name: regulation of action potential firing threshold


name: regulation of action potential firing rate


name: chemical synaptic transmission, postsynaptic


name: presynaptic process involved in chemical synaptic transmission


name: postsynapse to nucleus signaling pathway


name: cell surface receptor signaling pathway via STAT


name: acetylcholine receptor signaling pathway


name: negative regulation of lung blood pressure


name: 6-sulfoquinovose(1-) catabolic process to 3-sulfopropanediol(1-)


name: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5)


name: Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5), 2015


name: Child affected by parental relationship distress


name: Conviction in civil or criminal proceedings without imprisonment


name: Discord with neighbor, lodger, or landlord


name: Discord with social service provider, including probation officer, case manager, or social services worker


name: Disruption of family by separation or divorce


name: Encounter for mental health services for perpetrator of nonparental child abuse


name: Encounter for mental health services for perpetrator of nonparental child neglect


name: Encounter for mental health services for perpetrator of nonparental child psychological abuse


name: Encounter for mental health services for perpetrator of nonparental child sexual abuse


name: Encounter for mental health services for perpetrator of nonspousal adult abuse


name: Encounter for mental health services for perpetrator of parental child neglect


name: Encounter for mental health services for perpetrator of parental child psychological abuse


name: Encounter for mental health services for perpetrator of parental child sexual abuse


name: Encounter for mental health services for perpetrator of spouse or partner neglect


name: Encounter for mental health services for perpetrator of spouse or partner psychological abuse


name: Encounter for mental health services for perpetrator of spouse or partner violence, physical


name: Encounter for mental health services for perpetrator of spouse or partner violence, sexual


name: Encounter for mental health services for victim of child abuse by parent


name: Encounter for mental health services for victim of child neglect by parent


name: Encounter for mental health services for victim of child psychological abuse by parent


name: Encounter for mental health services for victim of child sexual abuse by parent


name: Encounter for mental health services for victim of nonparental child abuse


name: Encounter for mental health services for victim of nonparental child neglect


name: Encounter for mental health services for victim of nonparental child psychological abuse


name: Encounter for mental health services for victim of nonparental child sexual abuse


name: Encounter for mental health services for victim of nonspousal adult abuse


name: Encounter for mental health services for victim of spouse or partner neglect


name: Encounter for mental health services for victim of spouse or partner psychological abuse


name: Encounter for mental health services for victim of spouse or partner violence, physical


name: Encounter for mental health services for victim of spouse or partner violence, sexual


name: Exposure to disaster, war, or other hostilities


name: High expressed emotion level within family


name: Insufficient social insurance or welfare support


name: Lack of adequate food or safe drinking water


name: Other personal history of psychological trauma


name: Personal history (past history) of neglect in childhood


name: Personal history (past history) of physical abuse in childhood


name: Personal history (past history) of psychological abuse in childhood


name: Personal history (past history) of sexual abuse in childhood


name: Personal history (past history) of spouse or partner neglect


name: Personal history (past history) of spouse or partner psychological abuse


name: Personal history (past history) of spouse or partner violence, Physical


name: Personal history (past history) of spouse or partner violence, Sexual


name: Problem related to current military deployment status


name: Problem related to living in a residential institution


name: Relationship distress with spouse or intimate partner


name: Target of (perceived) adverse discrimination or persecution


name: Unavailability or inaccessibility of health care facilities


name: Unavailability or inaccessibility of other helping agencies


name: Unspecified problem related to unspecified psychosocial circumstances


name: {24 (ethinyl estradiol 0.02 MG / norethindrone acetate 1 MG Oral Capsule) / 4 (ferrous fumarate 75 MG Oral Capsule) } Pack


name: needles, disposable 31 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 28 gauge X 1/2" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 29 gauge X 1/2" MISCELL NEEDLE, DISPOSABLE


name: needles, safety 31 gauge X 5/16" MISCELL NEEDLE, DISPOSABLE


name: syringe with needle, insulin, safety, 1 mL 31 gauge X 5/16" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe,safety with needle,1 mL 26 gauge X 5/8" MISCELL SYRINGE, EMPTY DISPOSABLE


name: Dimethicone 0.15 g in 15 mL TOPICAL CREAM [Bling Magic Speedy Brightening Moisturizer]


name: HYALURONATE SODIUM 3.5 mg in 1 mL TOPICAL GEL [Hyaluronic Acid Gel]


name: 80% Soy Protein Supplement Powder for Suspension (Vanilla)


name: Calcium 15mg, Cherry Juice 30mL, Phosphorus 19mg, Potassium 50mg, Vitamin C 10mg Oral solution


name: Octinoxate 40 mg in 1 mL / Avobenzone 23 mg in 1 mL / Octocrylene 20 mg in 1 mL / Homosalate 20 mg in 1 mL TOPICAL LOTION [Nu Skin ageLOC Me Day S9 Broad Spectrum SPF 25]


name: ZINC OXIDE 35 mg in 1 g TOPICAL STICK [Rosehip and Lemongrass Lip SPF 15]


name: Neoke RA Lipoic Powder for Enteral Suspension


name: Whey Protein Concentrate Powder for Suspension (Vanilla)


name: WHEY 80 g in 100 g ORAL POWDER [AMERICANA WHEY Protein Supplement]


name: Avobenzone/Homosalate/Octisalate/Octocrylene 2%-4%-4%-2% Topical application Lotion


name: Dimethicone/Titanium Dioxide/Zinc Oxide 1.2%-1.5%-15% Topical application Cream


name: Nutritional Supplement Oral Liquid [Enfagrow Next Step]


name: CARBAMIDE PEROXIDE 8.3 g in 100 mL DENTAL GEL, DENTIFRICE [Lutooth Tooth Whitening Kit]


name: ZINC OXIDE 227.5 mg in 1 g TOPICAL CREAM [Raw Elements Lip Rescue 30 Broad Spectrum SPF 30]


name: ZINC OXIDE 227.5 mg in 1 g TOPICAL STICK [Raw Elements Eco 30 Broad Spectrum SPF 30]


name: ZINC OXIDE 230 mg in 1 mL TOPICAL CREAM [Raw Elements Eco Formula 30 Broad Spectrum SPF 30]


name: DIMETHICONE 2 g in 100 g / OCTINOXATE 7.5 g in 100 g / OXYBENZONE 2.5 g in 100 g TOPICAL STICK [Blistex Deep Renewal International]


name: syringe with needle,disposable,insulin 1 mL 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin,0.3 mL 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: syringe with needle,insulin,0.5 mL 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: acetylcarnitine 1 gram/scoop ORAL POWDER (GRAM)


name: medium chain triglycerides 5.84 kcal/gram ORAL POWDER (GRAM)


name: pediatric nutrition,milk based,iron/docosahexaenoic acid 0.03 gram-0.7 kcal/mL ORAL LIQUID (ML)


name: BAG,URINARY DRAINAGE 2000ML COVIDIEN #3512V


name: BRIEF,TRANQUILITY AIR PLUS XXXX-LARGE #2195


name: CATHETER,EXTERNAL X-LARGE KIT UROCARE #521140


name: CATHETER,INTERMITTENT APOGEE 14FR H#11426


name: CATHETER,INTERMITTENT APOGEE 14FR H#91426


name: CATHETER,INTERMITTENT VAPRO PLUS 14FR H #71144


name: CATHETER,INTERMITTENT,CLOSED SYSTEM 12FR CURE #CS12


name: CATHETER,INTERMITTENT,MAGIC3 10FR ROCHESTER #53310


name: CATHETER,SPEEDICATH COMPACT COLOPLAST #28702


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1401


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1402


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1403


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1404


name: DRESSING,POLYMEM AG FINGER/TOE,FERRIS #1405


name: SUCTION SET,SUCTION PRO 72 14FR CLOSED CATHETER #Z120N-14


name: SUCTION TUBE ATTACHMENT DEVICE MEDLINE #DYND52130


name: SUCTION TUBE ATTACHMENT DEVICE SAGE #6629


name: TRANSPARENT DRESSING W/BORDER 4IN X 4.5IN


name: PAD,FOAM 0.25IN X 18IN X 72IN BIACARE #5301


name: PAD,FOAM 0.5IN X 18IN X 72IN BIACARE #5302


name: Glycerin 0.5 g in 2 g TOPICAL GEL [Double S Essence Clean 2g 5ea]


name: Glycerin 3.75 g in 15 g TOPICAL GEL [Double S Essence Clean]


name: Lidocaine/Prilocaine 2.5%-2.5% Topical application Cream [Venipuncture CPI]


name: syringe with needle,insulin 0.3 mL (half unit mark) 31 gauge X 1/4" MISCELL SYRINGE, EMPTY DISPOSABLE


name: AVOBENZONE 3 g in 100 mL / HOMOSALATE 4 g in 100 mL / OCTISALATE 4.5 g in 100 mL / OCTOCRYLENE 2.6 g in 100 mL TOPICAL LOTION [Olay Age Defying Anti-Wrinkle Day Broad Spectrum SPF 15]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.82 g in 100 mL TOPICAL CREAM [Sable Long Wear Makeup Broad Spectrum SPF 20]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.82 g in 100 mL TOPICAL CREAM [Caramel Long Wear Makeup Broad Spectrum SPF 20]


name: GLYCERIN 1.98 mg in 1 mL TOPICAL CREAM [Renovating Regenerating Nourishing Cream]


name: OCTISALATE 3 g in 100 mL / ZINC OXIDE 6.82 g in 100 mL TOPICAL CREAM [Earth Long Wear Makeup Broad Spectrum SPF 20]


name: GLYCERIN 0.25 mg in 1 mL TOPICAL CREAM [Renovating Regenerating Serum]


name: GLYCERIN 7.8 mg in 1 mL TOPICAL CREAM [Renovating Regenerating Moisturizing Cream]


name: ZINC OXIDE 9.45 mg in 1 mL TOPICAL CREAM [Light Beam Hand Repair Cream Broad Spectrum SPF 18]


name: Benzoyl Peroxide;Benzoyl Peroxide;Gel, Multi Ingredient 2.5%; 5%; NA Multiple Routes Kit


name: Biotin/Cholecalciferol/Copper/Cyanocobalamin/Folic Acid/Heme Iron Polypeptide/Iodine/Iron Polysaccharide/Niacin/Pantothenic Acid/Pyridoxine/Riboflavin/Selenium/Thiamine/Vitamin E/Zinc;Docosahexaenoic Acid/Docosapentaenoic Acid/Linolenic Acid 30 MCG-400 IU-0.8 MG-12 MCG-1 MG-6 MG-250 MCG-28 MG-17 MG-10 MG-50 MG-1.6 MG-65 MCG-1.5 MG-10 IU-4.5 MG; 200 MG-2.5 MG-0.5 MG Oral Kit


name: Bupivacaine Hydrochloride;Isopropyl Alcohol;Lidocaine Hydrochloride;Povidone Iodine 0.25%; 70%; 1%; 10% Multiple Routes Kit [Active Injection Kit LM-2]


name: Bupivacaine Hydrochloride;Povidone Iodine;Triamcinolone Acetonide 0.5%; 10%; 40 MG/1 ML Multiple Routes Kit [Active Injection Kit KM]


name: Capsaicin/Menthol/Methyl Salicylate;Gabapentin 0.0375%-5%-20%; 300 MG Multiple Routes Kit


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Lidocaine Hydrochloride;Povidone Iodine 10 MG/1 ML; 70%; 1%; 10% Multiple Routes Kit [Active Injection Kit DL]


name: Dexamethasone Sodium Phosphate;Isopropyl Alcohol;Povidone Iodine 10 MG/1 ML; 70%; 10% Multiple Routes Kit [Active Injection Kit D]


name: Diclofenac Sodium;Isopropyl Alcohol 1.5%; 70% Topical application Kit


name: Gabapentin;Lidocaine 600 MG; 5% Multiple Routes Kit


name: Isopropyl Alcohol;Lidocaine Hydrochloride;Methylprednisolone Acetate 70%; 1%; 40 MG/1 ML Multiple Routes Kit [Active Injection Kit L]


name: Lidocaine/Prilocaine;Povidone Iodine;Sodium Chloride 2.5%-2.5%; 1%; 0.9% Multiple Routes Kit


name: Venetoclax;Venetoclax;Venetoclax 10 MG; 50 MG; 100 MG Oral Tablet


name: Cleanser Topical application Solution [Vanicream Gentle Facial Cleanser]


name: Gabapentin;Lidocaine 600 MG; 5% Multiple Routes Kit [Convenience Pak]


name: Ammonia/Ethanol;Lidocaine Hydrochloride;Povidone Iodine;Triamcinolone Acetonide 15%-35%; 1%; 10%; 40 MG/1 ML Multiple Routes Kit [Active Injection Kit KL-3]


name: {60 (lenvatinib 4 MG Oral Capsule [Lenvima]) } Pack [Lenvima 8]


name: {30 (lenvatinib 10 MG Oral Capsule) / 60 (lenvatinib 4 MG Oral Capsule) } Pack


name: AVOBENZONE 0.9 g in 100 g / OCTOCRYLENE 2 g in 100 g / OXYBENZONE 1.5 g in 100 g TOPICAL LOTION [Meijer SPF 8]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 13 g in 100 g / OCTOCRYLENE 2 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [ULTA FACE SPF 30]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 5.5 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4 g in 100 g TOPICAL LOTION [Meijer Sheer Moisturing SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 11.7 g in 100 g / OCTISALATE 4.5 g in 100 g / OCTOCRYLENE 4.5 g in 100 g / OXYBENZONE 5.4 g in 100 g TOPICAL LOTION [Meijer Sport SPF 50]


name: TITANIUM DIOXIDE 5.3 g in 100 g / ZINC OXIDE 7 g in 100 g TOPICAL CREAM [BB Broad Spectrum SPF 15 Light]


name: ZINC OXIDE 20 g in 100 g TOPICAL STICK [Premium Natural Sunscreen Broad Spectrum SPF 30 Baby Bum]


name: aluminum phosphate / dimethicone / magnesium hydroxide


name: CSF in left side of metencephalon part of fourth ventricle


name: Portion of renal filtrate in loop of Henle


name: Portion of urine in collecting duct of renal tubule


name: Portion of renal filtrate in proximal convoluted tubule


name: Portion of renal filtrate in distal convoluted tubule


name: Portion of renal filtrate in descending limb of loop of Henle


name: Portion of renal filtrate in ascending limb of loop of Henle


name: Portion of urine in collecting duct of renal tubule in right kidney


name: Portion of urine in collecting duct of renal tubule in left kidney


name: CSF in right side of medulla part of fourth ventricle


name: CSF in left side of medulla part of fourth ventricle


name: CSF in right side of metencephalon part of fourth ventricle


name: Send document that conforms to C-CDA R1.1 template


name: Send document that conforms to C-CDA R1.1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to C-CDA R2.0 template


name: Send document that conforms to C-CDA R2.0 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to C-CDA R2.1 template


name: Send document that conforms to C-CDA R2.1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to CDP Set 1 R1.0 template:Scope.modifier.doc template:Pt:X12^277:-


name: Send document that conforms to CDP Set 1 R1.0 template


name: Send document that conforms to CDP Set 1 R1.1 template


name: Send document that conforms to CDP Set 1 R1.1 template:Scope.modifier.doc template:Pt:X12^277:-


name: Setting of exposure to illness:Type:Pt:^Patient:Nom


name: Public health laboratory ask at order entry panel


name: Public health laboratory ask at order entry panel:-:-:^Patient:-


name: Pulmonary function test panel:-:Pt:Respiratory system:-


name: Referring physician phone number:Tele:Pt:Provider:Nom


name: {90 (insulin, regular, human 4 UNT Inhalation Powder [Afrezza]) / 90 (insulin, regular, human 8 UNT Inhalation Powder [Afrezza]) } Pack [Afrezza Titration Pack]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Mili 28 Day]


name: {7 (ethinyl estradiol 0.035 MG / norgestimate 0.18 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.215 MG Oral Tablet) / 7 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Tri-Mili 28 Day]


name: Other genomic reference sequence coding system OID:URI:Pt:^Patient:Nom


name: Other transcript reference sequence coding system OID:URI:Pt:^Patient:Nom


name: Structural variant ISCN name:Find:Pt:^Patient:Nom


name: Trimester at onset of illness:Time:Pt:^Patient:Ord


name: Source used for population RMR:Type:Pt:Reference source:Nom


name: Source used for predicted RMR:Type:Pt:Reference source:Nom


name: Source used for reported activity metabolic rate


name: Source used for reported activity metabolic rate:Type:Pt:Reference source:Nom


name: Source used to adjust activity MET:Type:Pt:Reference source:Nom


name: Source used to estimate activity metabolic rate


name: Source used to estimate activity metabolic rate:Type:Pt:Reference source:Nom


name: State or province of birth:Loc:Pt:^Patient:Nom


name: Post-discharge provider practice address


name: Transfer summary note - recommended C-CDA R2.0 sections


name: PROMIS short form - cognitive function 8a - version 2.0


name: Preoperative measures for patient safety panel


name: Fractional flow reserve performed:Find:Pt:^Patient:Ord


name: Frequency of bone-strengthening physical activity:NRat:RptPeriod:^Patient:Qn


name: Frequency of bone-strengthening physical activity


name: Frequency of moderate to vigorous aerobic physical activity:NRat:RptPeriod:^Patient:Qn


name: Frequency of moderate to vigorous aerobic physical activity


name: Frequency of muscle-strengthening physical activity:NRat:RptPeriod:^Patient:Qn


name: Frequency of muscle-strengthening physical activity


name: Deprecated t(9;22)(q34.1;q11)(ABL1,BCR) fusion transcript in Bone marrow by Molecular genetics method


name: Tissue perfusion assessment panel:-:Pt:^Patient:-


name: allogeneic hematopoietic stem cell transplant


name: Complex variant HGVS name:Find:Pt:^Patient:Nom


name: Sample variant allelic frequency:NFr:Pt:^Patient:Qn


name: Enhanced discharge summary - recommended CDP Set 1 R1.0 sections:-:Pt:{Setting}:-


name: Document template attachment request modifier codes:-:Pt:X12^277:-


name: Composite triage and nursing note - recommended IHE set:-:Pt:^Patient:-


name: GDAP1 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Genomic structural variant copy number:Num:Pt:^Patient:Qn


name: Genomic structural variant name:Find:Pt:^Patient:Nom


name: Transfer summary note - recommended C-CDA R2.0 sections:-:Pt:{Setting}:-


name: Transfer summary note - recommended C-CDA R2.1 sections:-:Pt:{Setting}:-


name: Transfer summary note - recommended C-CDA R2.1 sections


name: Composite triage and nursing note - recommended IHE set


name: {1 (acetaminophen 21.7 MG/ML / dextromethorphan hydrobromide 0.667 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) / 1 (acetaminophen 21.7 MG/ML / diphenhydramine hydrochloride 0.833 MG/ML / phenylephrine hydrochloride 0.333 MG/ML Oral Solution) } Pack


name: Evaluation and management of workers compensation form


name: Document template attachment request modifier codes


name: Verified availability of correct implants and any special equipment or requirements


name: PROMIS short form - cognitive function 8a - version 2.0 raw score


name: Nutrition and fluid intake assessment panel


name: Catalogue of Somatic Mutations in Cancer (COSMIC)


name: Post-discharge provider practice phone number:Tele:Pt:Provider:Nom


name: Post-discharge provider practice address:Addr:Pt:Provider:Nom


name: Post-discharge provider practice name:ID:Pt:Provider:Nom


name: Post-discharge provider practice ID:ID:Pt:Provider:Nom


name: Cardiogenic shock within 24H prior to procedure:Hx:24H:^Patient:Ord


name: Cardiac arrest within 24H prior to procedure:Hx:24H:^Patient:Ord


name: Coronary stent end coordinates:Type:Pt:Coronary arteries:Nom


name: Coronary stent end segment:Type:Pt:Coronary arteries:Nom


name: Coronary stent end segment position:Type:Pt:Coronary arteries:Nom


name: Percutaneous coronary intervention performed


name: PROMIS short form - cognitive function 4a - version 2.0


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0 raw score


name: Varicella zoster virus surveillance panel:-:Pt:^Patient:-


name: Varicella zoster virus surveillance panel


name: Verified availability of correct implants and any special equipment or requirements:Find:Pt:^Patient:Ord


name: Verified two types of patient identification:Find:Pt:^Patient:Ord


name: Verified two types of patient identification


name: Discharge summary - recommended C-CDA R2.0 sections:-:Pt:{Setting}:-


name: Discharge summary - recommended C-CDA R2.1 sections:-:Pt:{Setting}:-


name: Evaluation and management of workers compensation form:Find:Pt:{Setting}:Doc:{Role}


name: Evaluation and management of workers compensation note:Find:Pt:{Setting}:Doc:{Role}


name: Intra-aortic balloon pump used:Find:Pt:^Patient:Ord


name: Date and time of surgery:TmStp:Pt:^Patient:Qn


name: Coronary stent start coordinates:Type:Pt:Coronary arteries:Nom


name: Coronary stent start segment:Type:Pt:Coronary arteries:Nom


name: Coronary stent number:Number:Duration of the procedure:Heart:Quantitative


name: Coronary stent start segment position:Type:Pt:Coronary arteries:Nom


name: Post-discharge provider practice telephone number


name: Evaluation and management of workers compensation note


name: Discharge summary - recommended C-CDA R2.1 sections


name: Other genomic reference sequence coding system OID


name: PROMIS item bank - cognitive function - version 2.0


name: PROMIS short form - cognitive function 4a - version 2.0 raw score


name: PROMIS cognitive function - version 2.0 T-score


name: Personal advance care plan R1.0 - recommended CDA sections


name: National health care surveys report R1 - recommended CDA set


name: Meeting recommended guidelines for physical activity


name: LOINC Document Ontology associated observations panel


name: Performed preoperative time-out assessment


name: PROMIS short form - cognitive function 6a - version 2.0


name: PROMIS cognitive function - abilities subset - version 2.0 T-score


name: Enhanced discharge summary - recommended CDP Set 1 R1.1 sections


name: Percutaneous coronary intervention performed:Find:Pt:Heart:Ord


name: CYP1A2 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: CYP2C9 gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: LOINC Document Ontology associated observations panel:-:Pt:Clinical document:-


name: Master HL7 genetic variant reporting panel:-:Pt:^Patient:-


name: (Dermatophagoides pteronyssinus+Cat dander+Cat epithelium+Horse dander+Dog dander+Rabbit epithelium) Ab.IgE:ACnc:Pt:Ser:Qn


name: Master HL7 genetic variant reporting panel


name: Enhanced discharge summary - recommended CDP Set 1 R1.0 sections


name: Other transcript reference sequence coding system OID


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0 raw score


name: Medical equipment or product list:Find:Pt:{Setting}:Doc:{Role}


name: Medication usage implications panel:-:Pt:^Patient:-


name: Meeting recommended guidelines for physical activity:Find:Pt:^Patient:Ord


name: Method used to measure RMR:Type:Pt:^Patient:Nom


name: National health care surveys report R1 - recommended CDA set:-:Pt:^Patient:-


name: Discharge summary - recommended C-CDA R2.0 sections


name: Notary commission expiration date:Date:Pt:^Witness:Nom


name: Nutrition and fluid intake assessment panel:-:Pt:^Patient:-


name: Absolute aerobic exercise intensity:Type:Pt:^Patient:Ord


name: Percutaneous coronary intervention site:Anat:Pt:*:Nom


name: Performed preoperative time-out assessment:Find:Pt:^Patient:Ord


name: Personal advance care plan R1.0 - recommended CDA sections:-:Pt:{Setting}:-


name: Physical activity guideline used:Type:Pt:Reference source:Nom


name: Physical activity panel:-:Reporting period:^Patient:-


name: Enhanced discharge summary - recommended CDP Set 1 R1.1 sections:-:Pt:{Setting}:-


name: Preoperative measures for patient safety panel:-:Pt:^Patient:-


name: Preoperative verification process panel:-:Pt:^Patient:-


name: PRNP gene targeted mutation analysis:Find:Pt:Bld/Tiss:Doc:Molgen


name: Safety issue assessment note:Find:Pt:{Setting}:Doc:{Role}


name: PROMIS cognitive function - abilities subset - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS cognitive function - version 2.0 T-score:Tscore:Pt:^Patient:Qn:PROMIS


name: PROMIS item bank - cognitive function - abilities subset - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS item bank - cognitive function - abilities subset - version 2.0


name: PROMIS item bank - cognitive function - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function - abilities subset 8a - version 2.0 raw score


name: PROMIS short form - cognitive function 4a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function 4a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function 6a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function 6a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: PROMIS short form - cognitive function 6a - version 2.0 raw score


name: PROMIS short form - cognitive function 8a - version 2.0:-:7 days:^Patient:-:PROMIS


name: PROMIS short form - cognitive function 8a - version 2.0 raw score:Score:Pt:^Patient:Qn:PROMIS


name: laboratory processing of microbial specimen to include culture and sensitivity studies, preparation and transmission of written report


name: non-ionizing diagnostic procedure capable of quantifying, monitoring, and recording changes in structure of enamel, dentin, and cementum


name: scaling in presence of generalized moderate or severe gingival inflammation - full mouth, after oral evaluation


name: scaling and debridement of a single implant in the presence of mucositis, including inflammation, bleeding upon probing and increased pocket depths; includes cleaning of the implant surfaces, without flap entry and closure?


name: consultation with a medical health care professional


name: dental case management - addressing appointment compliance barriers


name: dental case management - care coordination


name: dental case management - motivational interviewing


name: dental case management - patient education to improve oral health literacy


name: distal shoe space maintainer - fixed, unilateral - per quadrant


name: Cyclopentasiloxane/Dimethicone/Vinyl Dimethicone Crosspolymer Topical application Gel/Jelly [Solu-K]


name: Neoke BCAA4 Powder for Enteral Suspension


name: Nutricia SHS Phlexy-10 Black Currant/Apple Powder


name: Nutricia Periflex LQ PKU Powder (Orange Creme)


name: Nutricia Periflex LQ PKU Powder (Berry Creme)


name: Nutricia Periflex Junior Plus PKU Powder (Vanilla)


name: Aurora Unifine Pentips Plus 31G 5/16 inch Short Pen Needle


name: Aurora Unifine Pentips Plus 31G 3/16 inch Mini Pen Needle


name: Aurora Unifine Pentips Plus 31G 1/4 inch Ultra Short Pen Needle


name: Anti-Static Compact Space Chamber Plus with Mask (Small)


name: Anti-Static Compact Space Chamber Plus with Mask (Medium)


name: Anti-Static Compact Space Chamber Plus with Mask (Large)


name: Aurora Unifine Pentips Plus 32G 5/32 inch Micro Pen Needle


name: My MDI Portable Nebulizer Procedure Pack


name: Nutricia Periflex Junior Plus PKU Powder (Orange)


name: Nutricia Periflex Junior Plus PKU Powder (Berry)


name: Nutricia Periflex Early Years PKU Powder


name: Nutricia MSUD Lophlex LQ Enteral Suspension (Mixed Berry)


name: Nutricia KetoCal 4:1 Enteral Suspension (Vanilla)


name: Nutricia HCU Lophlex LQ Enteral Suspension (Mixed Berry)


name: Nutricia Periflex Advance PKU Powder (Orange)


name: Nutricia Neocate Junior with Prebiotics Powder (Vanilla)


name: Nutricia Neocate Junior with Prebiotics Powder (Strawberry)


name: Nutricia Neocate Junior with Prebiotics Powder


name: Nutricia Neocate Junior Powder (Tropical)


name: Nutricia SHS XPhe Maxamum Powder (Orange)


name: Nutricia SHS XMet Maxamum Powder (Orange)


name: Nutricia SHS UCD Anamix Junior Powder (Vanilla)


name: Fluocinolone Acetonide;Urea 0.01%; 20% Topical application Kit [Noxipak Kit]


name: CVS Severe Daytime/Nighttime Multi-Symptom Cold/Flu Relief Twin Pack


name: CVS Cold Relief Daytime/Nighttime Multi-Symptom Cool Blast Caplet


name: CVS Lip Treatment Petroleum Jelly Lip Balm


name: CVS Children's Clear Chewable Tablet (Vanilla)


name: 5-Methyltetrahydrofolic Acid/Glucosamine Hydrochloride 30 MG Oral Tablet [XaQuil XR]


name: l-methylfolate 30 mg oral tablet, extended release


name: BD Safety-Lok Blood Collection Set, 23g 3/4"


name: Unifine Pentips Plus Pen Needles 32g 4mm


name: Unifine Pentips Plus Pen Needles 31g 8mm


name: Unifine Pentips Plus Pen Needles 31g 5mm


name: Monoject Insulin Syringe 0.5cc 30g 5/16"


name: BD Syringe Safety Luer-Lok 1 cc 25g 5/8"


name: Citrulline 1 GM Oral Tablet [Citrulline Easy]


name: Silver 1.2% Topical application Dressing [Aquacel Ag Foam Dressing]


name: Camphor/Menthol/Methyl Salicylate;Diclofenac Sodium 3.1%-6%-10%; 1.5% Multiple Routes Kit [Inflamma-K]


name: Fluocinolone Acetonide;Urea 0.01%; 20% Topical application Kit


name: Dimethicone;Lidocaine 5%; 5% Multiple Routes Kit


name: Camphor/Menthol;Sumatriptan Succinate 4%-10%; 50 MG Multiple Routes Kit


name: Camphor/Menthol/Methyl Salicylate;Diclofenac Sodium 3.1%-6%-10%; 1.5% Multiple Routes Kit


name: Cyclopentasiloxane/Dimethicone Topical application Gel/Jelly


name: Dimethicone 0.09 g in 9 g TOPICAL STICK [PANDAS DREAM SO COOL EYE SERUM]


name: {21 (ethinyl estradiol 0.035 MG / norgestimate 0.25 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Femynor 28 Day]


name: Glycerin 4.0 g in 200 mL TOPICAL CREAM [2X FIRST ESSENCE]


name: Glycerin 3.0 g in 50 g / Niacinamide 1.0 g in 50 g TOPICAL CREAM [PANDAS DREAM MAGIC]


name: AVOBENZONE 3 g in 75 mL / OCTINOXATE 7.5 g in 75 mL / OCTISALATE 4 g in 75 mL / OXYBENZONE 2 g in 75 mL TOPICAL CREAM [Day Care for Hands Broad Spectrum SPF 15 Jafra]


name: Titanium Dioxide 1.86 g in 45 mL / Octinoxate 1.80 g in 45 mL / Zinc Oxide 1.29 g in 45 mL TOPICAL CREAM [MY SUNNY POWDE RY FINISH SUN MILK]


name: Octinoxate 2.75 g in 50 mL / Octisalate 2.50 g in 50 mL / ENSULIZOLE 2.00 g in 50 mL / AVOBENZONE 1.50 g in 50 mL TOPICAL CREAM [TIMELESS FERMENT SANIL SUN]


name: GLYCERIN 13 mg in 1 mL TOPICAL LIQUID [3 en 1 Cleanser. Deep Cleansing]


name: DIMETHICONE 1.52 mg in 1 mL TOPICAL LIQUID [Cleanser Dermopurifying Oily Skin]


name: DIMETHICONE 0.95 mg in 1 mL / GLYCERIN 6.125 mg in 1 mL TOPICAL LIQUID [Cleanser Sensitive Skin]


name: ZINC OXIDE 60 mg in 1 mL / TITANIUM DIOXIDE 45 mg in 1 mL TOPICAL CREAM [Tinted Radiance Moisturizer Broad Spectrum SPF 32]


name: DIMETHICONE 0.01 g in 100 mL TOPICAL CREAM [ARGAN AIR WATER BANG ESSENCE]


name: Lidocaine/Prilocaine;Triamcinolone Acetonide 2.5%-2.5%; 40 MG/1 ML Multiple Routes Kit [DermacinRx Cinlone-I CPI]


name: DIMETHICONE 0.76 mg in 1 mL / GLYCERIN 5.35 mg in 1 mL TOPICAL LIQUID [Cleanser Balancing]


name: OCTINOXATE 6.9 g in 100 mL / OCTISALATE 3 g in 100 mL / ZINC OXIDE 4 g in 100 mL TOPICAL CREAM [BOTANICAL SOOTHING SPF-30]


name: {21 (ethinyl estradiol 0.02 MG / levonorgestrel 0.1 MG Oral Tablet) / 7 (inert ingredients 1 MG Oral Tablet) } Pack [Larissia 28 Day Pack]


name: {1 (dextromethorphan hydrobromide 2 MG/ML / guaifenesin 40 MG/ML Oral Solution) / 1 (dextromethorphan hydrobromide 3 MG/ML / doxylamine succinate 1.25 MG/ML Oral Solution) } Pack


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 13 g in 100 g / OCTOCRYLENE 1 g in 100 g / OCTISALATE 5 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Walgreens Sport Faces SPF 30]


name: GLYCERIN 0.25 g in 5 mL TOPICAL SOLUTION [ZNSP Ampoule]


name: GLYCERIN 0.16 g in 8 g TOPICAL CREAM [ZNSP Repair]


name: TITANIUM DIOXIDE 3.2 g in 100 g / ZINC OXIDE 4 g in 100 g TOPICAL LOTION [Meijer Kids Tear Free SPF 50]


name: GREEN TEA LEAF 44.71 g in 55 mL TOPICAL CREAM [The Chok Chok Green Tea Watery Essence]


name: Glycerin 9.3 g in 60 mL / Niacinamide 1.2 g in 60 mL TOPICAL CREAM [NATURALTH GOAT MILK PREMIUM TONE UP]


name: Glycerin 9 g in 150 mL TOPICAL EMULSION [NATURALTH GOAT MILK MOISTURE]


name: Glycerin 0.15 g in 150 mL TOPICAL LIQUID [NATURALTH GOAT MILK MOISTURE TONER]


name: Dimethicone 0.3 g in 75 mL TOPICAL CREAM [MIZON ALL IN ONE SNAIL REPAIR]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Unflavored Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Tropical Fruits Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Pineapple Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Peach Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Orange Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Mango Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Lemon-Lime Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Horchate Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Grape Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Coconut Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Cherry Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Bubbe Gum Flavor]


name: DEXTROSE MONOHYDRATE 25 g in 1 L / POTASSIUM CITRATE 20 meq in 1 L / SODIUM CHLORIDE 45 meq in 1 L / SODIUM CHLORITE 35 meq in 1 L / ZINC 35 meq in 1 L ORAL LIQUID [SUEROLYTE Oral Electrolyte Solution Apple Flavor]


name: OCTINOXATE 6 g in 100 mL / ZINC OXIDE 3 g in 100 mL TOPICAL CREAM [Covergirl cgsmoothers BB Tinted Moisturizer Broad Spectrum SPF 21 (all shades)]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 8 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 4 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Meijer Sheer SPF 30]


name: AVOBENZONE 3 g in 100 g / HOMOSALATE 10 g in 100 g / OCTOCRYLENE 6 g in 100 g TOPICAL LOTION [Rite Aid SPF 50]


name: AVOBENZONE 2 g in 100 g / HOMOSALATE 13 g in 100 g / OCTISALATE 5 g in 100 g / OCTOCRYLENE 2 g in 100 g / OXYBENZONE 4 g in 100 g TOPICAL LOTION [Meijer Oil Free Faces SPF 30]


name: AVOBENZONE 1.8 g in 100 g / HOMOSALATE 7 g in 100 g / OCTOCRYLENE 5 g in 100 g TOPICAL LOTION [Rite Aid SPF 30]


name: ZINC OXIDE 7 g in 100 g / TITANIUM DIOXIDE 4.7 g in 100 g TOPICAL CREAM [BB Broad Spectrum SPF 15 Medium]


name: TITANIUM DIOXIDE 57.8 mg in 1 mL / ZINC OXIDE 37.4 mg in 1 mL TOPICAL CREAM [Island Remedy All-day Revitalizing Moisturizer with SPF 30]


name: TITANIUM DIOXIDE 4.7 g in 100 g / ZINC OXIDE 7 g in 100 g TOPICAL CREAM [BB Broad Spectrum SPF 15 Light to Medium]


name: TITANIUM DIOXIDE 3.2 g in 100 g / ZINC OXIDE 4 g in 100 g TOPICAL LOTION [Meijer Baby Tear Free SPF 50]


name: Ascorbic Acid/Potassium/Sodium;Polyethylene Glycol 3350 50%-75 MG/1.5 GM-70 MG/1.5 GM; 17 GM/1 DOSE Oral Powder for Solution [Gialax]


name: sumatriptan succinate/menthol/camphor 50 mg-10 %-4 % MISCELL KIT, GEL AND TABLET


name: lidocaine/dimethicone 5 %-5 % TOPICAL KIT, PATCH, MEDICATED AND CREAM


name: nut tx imp.digest.fxn, soy, lac-reduced/dha/epa/FOS/inulin 0.09 gram-1 kcal/mL ORAL LIQUID (ML)


name: fluocinolone acetonide/urea/silicone, adhesive 0.01 %-20 % TOPICAL KIT


name: emollient combination no.10 TOPICAL CREAM (GRAM)


name: doxycycline monohydrate 100 % MISCELL POWDER (GRAM)


name: diclofenac sodium/methyl salicylate/menthol/camphor 1.5 %-10 %-6 %-3.1 % TOPICAL KIT, PATCH, MEDICATED AND SOLUTION DROPS


name: catheter male,external 22 mm to 25 mm MISCELL EACH


name: cardioplegic solution no.18 (induction 8:1) 70 mEq/300 mL (potassium) PERFUSION PLASTIC BAG, PERFUSION (ML)


name: amino acids/protein hydrolysate/fiber 15 gram-100 kcal/30 mL ORAL LIQUID IN PACKET (ML)


name: amino acids/protein hydrolysate/fiber 15 gram-100 kcal/30 mL ORAL LIQUID (ML)


name: {60 (lenvatinib 4 MG Oral Capsule) } Pack


name: KIT, PATCH, MEDICATED AND SOLUTION DROPS


name: irrigating solution non-surgical combo no.1


name: balanced salt irrigation solution combination no.4


name: cardioplegic solution no.17 (induction 4:1)


name: enteral pump accessory for fat hydrolysis


name: nutritional therapy, phenylketonuria (PKU), no.62


name: diluent for Haemoph b vacc (tet-conj.)(0.9 % NaCl)


name: camphor / Eucalyptus oil / levomenthol / peppermint oil / thymol


name: influenza A virus A/California/7/2009 (H1N1) antigen / influenza A virus A/Hong Kong/4801/2014 (H3N2) antigen / influenza B virus B/Brisbane/60/2008 antigen / influenza B virus B/Phuket/3073/2013 antigen


name: TRACH TUBE,SZ 10 SINGLE CANNULA SHLY 10SCT


name: POUCH,DRAINABLE,CENTER POINT LOCK H#8817


name: CATHETER,INTERMITTENT,MAGIC3 12FR ROCHESTER #50612


name: CATHETER,INTERMITTENT COUDE 14FR PECO #PU614C


name: CATHERIZATION SET,INTERMITTENT 12FR VAPRO PLUS H#74124


name: BRIEF,BREATHABLE EXTRA ABSORBENT X-SMALL ATTENDS


name: BANDAGE,ELASTIC MATRIX 6IN X 5YD,LF,STERILE


name: BANDAGE,ELASTIC MATRIX 4IN X 5YD,LF,STERILE


name: BANDAGE,ELASTIC MATRIX 3IN X 5YD,LF,STERILE


name: Introduction of Uridine Triacetate into Mouth and Pharynx, External Approach, New Technology Group 2


name: Introduction of Inactivated Coagulation Factor Xa into Central Vein, Percutaneous Approach, New Technology Group 2


name: Introduction of Inactivated Coagulation Factor Xa into Peripheral Vein, Percutaneous Approach, New Technology Group 2


name: Reposition of Thoracic Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2


name: Reposition of Cervical Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2


name: Reposition of Lumbar Vertebra using Magnetically Controlled Growth Rod(s), Open Approach, New Technology Group 2


name: Perfusion of Urinary System Donor Organ, Single


name: Perfusion of Hepatobiliary System and Pancreas Donor Organ, Single


name: Perfusion of Respiratory System Donor Organ, Single


name: Perfusion of Circulatory Donor Organ, Single


name: Monitoring of Skin and Breast Vascular Perfusion using Indocyanine Green Dye, External Approach


name: Monitoring of Gastrointestinal Vascular Perfusion using Indocyanine Green Dye, External Approach


name: Monitoring of Cardiac Vascular Perfusion using Indocyanine Green Dye, External Approach


name: Introduction of Destructive Agent into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Gas into Cranial Cavity and Brain, Open Approach


name: Introduction of Analgesics, Hypnotics, Sedatives into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Diagnostic Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Radioactive Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Therapeutic Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Anesthetic Agent into Cranial Cavity and Brain, Open Approach


name: Introduction of Electrolytic and Water Balance Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Nutritional Substance into Cranial Cavity and Brain, Open Approach


name: Introduction of Anti-inflammatory into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Anti-infective into Cranial Cavity and Brain, Open Approach


name: Introduction of Oxazolidinones into Cranial Cavity and Brain, Open Approach


name: Introduction of Antineoplastic, Monoclonal Antibody, into Cranial Cavity and Brain, Open Approach


name: Introduction of Other Antineoplastic into Cranial Cavity and Brain, Open Approach


name: Introduction of Liquid Brachytherapy Radioisotope into Cranial Cavity and Brain, Open Approach


name: Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Hematopoietic Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Cord Blood Stem Cells into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Bone Marrow into Central Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Hematopoietic Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Cord Blood Stem Cells into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unspecified Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Unrelated Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transfusion of Allogeneic Related Bone Marrow into Peripheral Vein, Percutaneous Approach


name: Transplantation of Left Hand, Syngeneic, Open Approach


name: Transplantation of Left Hand, Allogeneic, Open Approach


name: Transplantation of Right Hand, Syngeneic, Open Approach


name: Transplantation of Right Hand, Allogeneic, Open Approach


name: Transplantation of Face, Syngeneic, Open Approach


name: Transplantation of Face, Allogeneic, Open Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, External Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Tibial Surface, Open Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, External Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Tibial Surface, Open Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, External Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Femoral Surface, Open Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, External Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Hip Joint, Acetabular Surface, Open Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, External Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Left Knee Joint, Patellar Surface, Open Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, External Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Knee Joint, Patellar Surface, Open Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, External Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, Percutaneous Approach


name: Revision of Synthetic Substitute in Right Hip Joint, Acetabular Surface, Open Approach


name: Replacement of Left Knee Joint with Medial Unicondylar Synthetic Substitute, Open Approach


name: Replacement of Left Knee Joint with Medial Unicondylar Synthetic Substitute, Uncemented, Open Approach


name: Replacement of Left Knee Joint with Medial Unicondylar Synthetic Substitute, Cemented, Open Approach


name: Replacement of Right Knee Joint with Medial Unicondylar Synthetic Substitute, Open Approach


name: Replacement of Right Knee Joint with Medial Unicondylar Synthetic Substitute, Uncemented, Open Approach


name: Replacement of Right Knee Joint with Medial Unicondylar Synthetic Substitute, Cemented, Open Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Tibial Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Tibial Surface, Open Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Tibial Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Tibial Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Tibial Surface, Open Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Femoral Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Femoral Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Femoral Surface, Open Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Acetabular Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Hip Joint, Acetabular Surface, Open Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Patellar Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Left Knee Joint, Patellar Surface, Open Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Patellar Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Patellar Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Knee Joint, Patellar Surface, Open Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Acetabular Surface, Percutaneous Endoscopic Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Acetabular Surface, Percutaneous Approach


name: Removal of Synthetic Substitute from Right Hip Joint, Acetabular Surface, Open Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, External Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, Percutaneous Endoscopic Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, Percutaneous Approach


name: Revision of Neurostimulator Lead in Left Innominate Vein, Open Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, External Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, Percutaneous Endoscopic Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, Percutaneous Approach


name: Revision of Neurostimulator Lead in Right Innominate Vein, Open Approach


name: Revision of Neurostimulator Lead in Azygos Vein, External Approach


name: Revision of Monitoring Device in Azygos Vein, External Approach


name: Revision of Neurostimulator Lead in Azygos Vein, Percutaneous Endoscopic Approach


name: Revision of Monitoring Device in Azygos Vein, Percutaneous Endoscopic Approach


name: Revision of Neurostimulator Lead in Azygos Vein, Percutaneous Approach


name: Revision of Monitoring Device in Azygos Vein, Percutaneous Approach


name: Revision of Neurostimulator Lead in Azygos Vein, Open Approach


name: Revision of Monitoring Device in Azygos Vein, Open Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, External Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, Percutaneous Approach


name: Removal of Neurostimulator Lead from Left Innominate Vein, Open Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, External Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, Percutaneous Approach


name: Removal of Neurostimulator Lead from Right Innominate Vein, Open Approach


name: Removal of Neurostimulator Lead from Azygos Vein, External Approach


name: Removal of Monitoring Device from Azygos Vein, External Approach


name: Removal of Neurostimulator Lead from Azygos Vein, Percutaneous Endoscopic Approach


name: Removal of Monitoring Device from Azygos Vein, Percutaneous Endoscopic Approach


name: Removal of Neurostimulator Lead from Azygos Vein, Percutaneous Approach


name: Removal of Monitoring Device from Azygos Vein, Percutaneous Approach


name: Removal of Neurostimulator Lead from Azygos Vein, Open Approach


name: Removal of Monitoring Device from Azygos Vein, Open Approach


name: Insertion of Neurostimulator Lead into Left Innominate Vein, Percutaneous Endoscopic Approach


name: Insertion of Neurostimulator Lead into Left Innominate Vein, Percutaneous Approach


name: Insertion of Neurostimulator Lead into Left Innominate Vein, Open Approach


name: Insertion of Neurostimulator Lead into Right Innominate Vein, Percutaneous Endoscopic Approach


name: Insertion of Neurostimulator Lead into Right Innominate Vein, Percutaneous Approach


name: Insertion of Neurostimulator Lead into Right Innominate Vein, Open Approach


name: Insertion of Neurostimulator Lead into Azygos Vein, Percutaneous Endoscopic Approach


name: Insertion of Monitoring Device into Azygos Vein, Percutaneous Endoscopic Approach


name: Insertion of Neurostimulator Lead into Azygos Vein, Percutaneous Approach


name: Insertion of Monitoring Device into Azygos Vein, Percutaneous Approach


name: Insertion of Neurostimulator Lead into Azygos Vein, Open Approach


name: Insertion of Monitoring Device into Azygos Vein, Open Approach


name: Restriction of Left Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Endoscopic Approach


name: Restriction of Left Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach


name: Restriction of Left Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Open Approach


name: Restriction of Right Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Endoscopic Approach


name: Restriction of Right Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach


name: Restriction of Right Common Iliac Artery with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Open Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, Three or More Arteries, Percutaneous Endoscopic Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Endoscopic Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, Three or More Arteries, Percutaneous Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Percutaneous Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, Three or More Arteries, Open Approach


name: Restriction of Abdominal Aorta with Branched or Fenestrated Intraluminal Device, One or Two Arteries, Open Approach


name: Dilation of Lower Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Lower Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Lower Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Lower Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Foot Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Foot Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Foot Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Foot Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Foot Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Foot Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Peroneal Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Peroneal Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Peroneal Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Peroneal Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Peroneal Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Peroneal Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Peroneal Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Posterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Posterior Tibial Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Posterior Tibial Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Posterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Posterior Tibial Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Posterior Tibial Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Posterior Tibial Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Posterior Tibial Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Posterior Tibial Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Posterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Posterior Tibial Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Posterior Tibial Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Posterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Posterior Tibial Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Posterior Tibial Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Posterior Tibial Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Right Posterior Tibial Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Right Posterior Tibial Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Right Posterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Posterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Posterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Anterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Anterior Tibial Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Anterior Tibial Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Anterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Anterior Tibial Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Anterior Tibial Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Anterior Tibial Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Anterior Tibial Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Anterior Tibial Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Anterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Anterior Tibial Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Anterior Tibial Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Anterior Tibial Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Anterior Tibial Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Anterior Tibial Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Anterior Tibial Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Right Anterior Tibial Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Right Anterior Tibial Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Right Anterior Tibial Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Anterior Tibial Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Anterior Tibial Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Popliteal Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Popliteal Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Popliteal Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Popliteal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Popliteal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Popliteal Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Popliteal Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Popliteal Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Popliteal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Popliteal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Popliteal Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Popliteal Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Popliteal Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Popliteal Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Popliteal Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Popliteal Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Popliteal Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Popliteal Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Popliteal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Popliteal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Popliteal Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Popliteal Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Popliteal Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Popliteal Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Popliteal Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Right Popliteal Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Right Popliteal Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Right Popliteal Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Right Popliteal Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Popliteal Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Popliteal Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Femoral Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Femoral Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Femoral Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Femoral Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Femoral Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Left Femoral Artery with Four or More Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Femoral Artery with Three Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Femoral Artery with Two Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Femoral Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Femoral Artery with Two Drug-eluting Intraluminal Devices, Percutaneous Approach


name: Dilation of Left Femoral Artery with Four or More Intraluminal Devices, Open Approach


name: Dilation of Left Femoral Artery with Three Intraluminal Devices, Open Approach


name: Dilation of Left Femoral Artery with Two Intraluminal Devices, Open Approach


name: Dilation of Left Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Femoral Artery with Three Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Left Femoral Artery with Two Drug-eluting Intraluminal Devices, Open Approach


name: Dilation of Right Femoral Artery with Four or More Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Femoral Artery with Three Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Femoral Artery with Two Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Femoral Artery with Four or More Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach


name: Dilation of Right Femoral Artery with Three Drug-eluting Intraluminal Devices, Percutaneous Endoscopic Approach